Kidney Cancer Drug Shows Promise in Early Trial

WEDNESDAY, Nov. 30, 2016 — An experimental drug may show promise in treating kidney cancer, researchers say.
The drug CB-839 is the first to target an enzyme that cancer cells require to stay alive, researchers said. This stage 1 clinical trial…
Source: Topamax